Index Series developed by FTSE Russell in the United Kingdom. The index series select companies based on evaluations of their initiatives in the areas of Environmental, Social and Governance (ESG) activities.
External Assessment
Santen seeks to identify social issues and expectations for us through communication with stakeholders, in order to reflect such findings in our sustainability promotion activities.
Selected for ESG Indexes
Various ESG indexes are used to benchmark responsible investment. ESG indexes evaluate companies from environmental, social and governance (ESG) perspective, with the aim of promoting responsible investment from a long-term viewpoint. Santen Group's sustainability promotion efforts have been evaluated from the perspective of ESG and selected in ESG indexes inside and outside of Japan.
FTSE4Good Index Series
FTSE Russell (the trading name of FTSE International Limited and Frank Russell Company) confirms that Santen Pharmaceutical has been independently assessed according to the FTSE4Good criteria, and has satisfied the requirements to become a constituent of the FTSE4Good Index Series. Created by the global index provider FTSE Russell, the FTSE4Good Index Series is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE4Good indices are used by a wide variety of market participants to create and assess responsible investment funds and other products.
MSCI ESG Leaders Indexes
An index by MSCI (USA) that selects companies with the highest ESG rated performance in each sector from around the world.
THE INCLUSION OF Santen Pharmaceutical IN ANY MSCI INDEX, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT OR PROMOTION OF Santen Pharmaceutical BY MSCI OR ANY OF ITS AFFILIATES. THE MSCI INDEXES ARE THE EXCLUSIVE PROPERTY OF MSCI. MSCI AND THE MSCI INDEX NAMES AND LOGOS ARE TRADEMARKS OR SERVICE MARKS OF MSCI OR ITS AFFILIATES.
Sompo Sustainability Index
An index composed of corporations that achieved above a certain standard ESG scores in corporate surveys conducted by Sompo Risk Management & Health Care Inc. (in terms of E: environmental assessments) and by Integrex Inc. (in terms of S and G: social and corporate governance assessments).
Santen includes in all six ESG investment indexes selected by the Government Pension Investment Fund (GPIF)
The Company has been selected as a constituent of all six of the following indices used by Japan’s Government Pension Investment Fund (GPIF), one of the world’s largest pension fund, for ESG investment in Japanese companies.
FTSE Blossom Japan Index
A broad index developed by FTSE Russell in the United Kingdom. The index is incorporating overall ESG considerations.
FTSE Russell confirms that Santen Pharmaceutical has been independently assessed according to the index criteria, and has satisfied the requirements to become a constituent of the FTSE Blossom Japan Index. Created by the global index and data provider FTSE Russell, the FTSE Blossom Japan Index is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE Blossom Japan Index is used by a wide variety of market participants to create and assess responsible investment funds and other products.
FTSE Blossom Japan Sector Relative Index
A broad index developed by FTSE Russell in the United Kingdom. The index is incorporating overall ESG considerations. The index is comprised of companies with outstanding ESG initiatives which also have excellent management attitudes towards corporate climate change risks and opportunities.
FTSE Russell confirms that Santen Pharmaceutical has been independently assessed according to the index criteria, and has satisfied the requirements to become a constituent of the FTSE Blossom Japan Sector Relative Index. Created by the global index and data provider FTSE Russell, the FTSE Blossom Japan Sector Relative Index is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE Blossom Japan Sector Relative Index is used by a wide variety of market participants to create and assess responsible investment funds and other products.
MSCI Japan ESG Select Leaders Index
An index by MSCI (USA) that selects companies with relatively high ESG ratings in each sector from the constituent stocks of the parent index (MSCI Japan IMI Index). The index targets coverage of 50% of the parent index in terms of market capitalization.
MSCI Japan Empowering Women Index (WIN)
An index developed by MSCI in the United States. The index selects companies in various sectors that excel in gender diversity from among the top Japanese stocks by market capitalization.
THE INCLUSION OF Santen Pharmaceutical IN ANY MSCI INDEX, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CONSTITUTE A SPONSORSHIP, ENDORSEMENT OR PROMOTION OF Santen Pharmaceutical BY MSCI OR ANY OF ITS AFFILIATES. THE MSCI INDEXES ARE THE EXCLUSIVE PROPERTY OF MSCI. MSCI AND THE MSCI INDEX NAMES AND LOGOS ARE TRADEMARKS OR SERVICE MARKS OF MSCI OR ITS AFFILIATES.
Morningstar Japan ex-REIT Gender Diversity Tilt Index
An index based on an evaluation that Morningstar Inc. (USA) utilizes the data and scoring methodology of Equileap (Netherlands). It is designed to select Japanese companies that have strong gender diversity policies embedded in their corporate culture and that ensure equal opportunities to employees, irrespective of their gender.
Morningstar, Inc., and/or one of its affiliated companies (individually and collectively, “Morningstar”) has authorized Santen Pharmaceutical Co., Ltd. to use of the Morningstar Japan ex-REIT Gender Diversity Tilt Logo (“Logo”) to reflect the fact that, for the designated ranking year, Santen Pharmaceutical Co., Ltd. ranks in the top group of companies comprising the Morningstar® Japan ex-REIT Gender Diversity Tilt IndexSM (“Index”) on the issue of gender diversity in the workplace. Morningstar is making the Logo available for use by Santen Pharmaceutical Co., Ltd. for informational purposes. Santen Pharmaceutical Co., Ltd. use of the Logo should not be construed as an endorsement by Morningstar of Santen Pharmaceutical Co., Ltd. or as a recommendation, offer or solicitation to purchase, sell or underwrite any security associated with Santen Pharmaceutical Co., Ltd. The Index is designed to reflect gender diversity in the workplace in Japan, but Morningstar does not guarantee the accuracy, completeness or timeliness of the Index or any data included in it. Morningstar makes no express or implied warranties regarding the Index or the Logo, and expressly disclaim all warranties of merchantability or fitness for a particular purpose or use with respect to the Index, any data included in it or the Logo. Without limiting any of the foregoing, in no event shall Morningstar or any of its third party content providers have any liability for any damages (whether direct or indirect), arising from any party’s use or reliance on the Index or the Logo, even if Morningstar is notified of the possibility of such damages. The Morningstar name, Index name and the Logo are the trademarks or services marks of Morningstar, Inc. Past performance is no guarantee of future results.
S&P/JPX Carbon Efficient Index
An Index developed by S&P Dow Jones Indices in the United States. The index evaluates corporate performance in terms of disclosure of information carbon efficiency.
Recognition and Commendations by Third Parties
Below are the main recognition and commendations we have received.
| March 2025 | The Company has been certificated as Health and Productivity Management Organization Recognition Program 2025 (Large Enterprise Category) . |
|---|---|
| February 2025 | Selected as a Sustainability Yearbook Member in “The Sustainability Yearbook 2025” by S&P Global in the United States, gaining top 10% score in pharmaceutical sector. The Company has been selected as a member of “The Sustainability Yearbook” for four consecutive years since 2022. |
| January 2025 | The Company has been awarded a “Prime” rating in the “ISS ESG Corporate Rating” by ISS ESG, the responsible investment division of Institutional Shareholder Service (ISS), a leading global proxy advisory firm. |
| December 2023 | Claire Co., Ltd. has received an award for employment of persons with disabilities and support for social independence of the intellectually challenged. |
| 2023 | The Company has been certificated as Great Place To Work® in 17 countries, including the United Kingdom, China and United States of America and others.   |
| March 2022 | Claire Co., Ltd. has received an award for education support company by Osaka Prefectural Education Committee. |
| Feburary 2022 | The Company has been certilied as Digital Transformation Business Operator by Ministry of Economy, Trade and Industry.  |
| January 2022 | Santen SA Netherlands branch has been certificated as Top Employer in Netherlands.  |
| September 2021 | Claire Co., Ltd. has been certificated as Excellent Small and Medium-sized Employer Employing Persons with Disabilities (Monisu certification) by the Minister of Health, Labour and Welfare.  |
| January 2019 | ClaireCo., Ltd. a special subsidiary company got certified as a company which persons with disabilities work actively by Japan Association of Employers of Persons with Severe Disabilities, which is a trustee organization entrusted to the Ministry of Health, Labor and Welfare. |
| February 2018 | The Company was selected for the winner of the Corporate Governance of the year 2017 by the Japan Association of Corporate Directors. Recognized for: |
Official SNS
